HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Defendant On Criminal Steroid Charges Owns Firm FDA Warns On Stimulant Found In Supplement

Executive Summary

Georgia business records indicate the firm FDA warned on 21 May was established in 2017 by Jared Wheat and is registered with an address in an Atlanta suburb also used for Wheat’s Hi-Tech Pharmaceuticals. Wheat is facing 18 criminal charges listed in a 2017 indictment alleging he distributed steroid-spiked supplements and falsified regulatory compliance documents.

You may also be interested in...



US COVID-19 Claim Warnings Continue; Hi-Tech’s Problems Extend To Undeclared Allergens

Natural Adventure and PYRLess Group are latest firms to learn FDA, FTC continue monitoring the market for claims promoting supplements as COVID-19 treatments. Hi-Tech Pharmaceuticals recalls APS Nutrition Isomorph 28 and iForce Nutrition Mass Gainz due to undeclared allergens.

Supplement Firm Hi-Tech Pays For Another Round Of Refunds In FTC’s 15-Year Litigation

FTC is mailing 143,636 refund checks totaling more than $8.5m to consumers who bought three supplements marketed with false and misleading advertising by Hi-Tech Pharmaceuticals and several related companies.

Supplement GMP Inspections Slowing As FDA Makes 'Potential' Data Useful

FDA doesn't expect o continue increasing GMP inspections at the rate established from fiscal 2013 through 2017, says Cara Welch, assistant director of the office in the agency's Office of Dietary Supplement Programs."We're not going to keep growing at that rate because we have a lot of regulations we have to inspect and we're always resource strapped," she said at a recent industry conference.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150131

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel